Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) — Meldola, FC

Public research footprint of Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), compiled from the ClinicalTrials.gov public registry.

256

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Multiple Myeloma · Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Recently updated registry entries

NCT03625037 — First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell… (Active Not Recruiting)
NCT06425991 — A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or… (Active Not Recruiting)
NCT06662786 — A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.